Disruptive AI technology that is leading the future in impairment detection and healthcare screenings
CANNABIS AND ALCOHOL IMPAIRMENT
Our first-to-market AI product screens for Cannabis impairment and is being expanded to include screening for alcohol and opioids.
We are harnessing our AI technology to be used globally in healthcare, with our primary focus on COVID-19 screenings. PREDICTMEDIX can be deployed in settings outside of hospitals and healthcare facilities or at any location where people gather or where transmission security is paramount.
Our disruptive technology can detect mental illness at early stages giving healthcare practitioners the opportunity to provide proper care before their patient's condition worsens. Employers can use our technology to protect and care for the mental health of their workforce.
SHELDON KALES - CEO
DR. RAHUL KUSHWAH - COO
RAKESH MALHOTRA - CFO
NANDAN MISHRA - AI Lead
HIMANSHU UJJAWAL SINGH - Co-AI Lead
PRAVEEN KUMAR - Data Analytics Lead